
GLP-1 (glucagon-like peptide-1) receptor agonists are a class of medications that mimic a natural hormone involved in appetite regulation and blood sugar control.
Originally developed for type 2 diabetes management, this medication class — including semaglutide and tirzepatide — has become the leading option for medically supervised weight loss, with clinical studies demonstrating significant, sustained results when combined with lifestyle support.
You may be a candidate for GLP-1 therapy at our Lisle office if you have:
● A BMI of 30 or greater, or
● A BMI of 27 or greater with a weight-related health condition such as high blood pressure, type 2 diabetes, sleep apnea, or PMOS (formerly PCOS)
Every patient undergoes a comprehensive medical evaluation, including a review of health history and relevant lab work, before starting treatment.
If you’re ready to make a lasting change, our Medical Weight Loss in Lisle, IL programs are here to help you succeed. With expert guidance, customized planning, and proven strategies, you can achieve a healthier and more confident version of yourself.
Schedule your consultation today and take the first step toward long-term wellness.